Standard Biotools (LAB) Restructuring Costs (2013 - 2026)

Standard Biotools (LAB) has 7 years of Restructuring Costs data on file, last reported at $3.1 million in Q1 2026.

• On a quarterly basis, Restructuring Costs rose 98.45% year-over-year to $3.1 million in Q1 2026; TTM through Mar 2026 was $26.0 million, a 16.89% increase from a year earlier, with the FY2025 full-year figure at $14.8 million, down 47.17% from the prior year.
• Restructuring Costs for Q1 2026 stood at $3.1 million, down from $13.3 million in the prior quarter.
• Over the last five years, Restructuring Costs for LAB reached as high as $17.2 million in Q1 2024 and fell as low as -$1.2 million in Q4 2022.
• Historically, Restructuring Costs has averaged $4.7 million across 5 years, with a median of $2.3 million in 2023.
• Across the five-year window, Restructuring Costs jumped 1358.41% in 2024 and tumbled 90.96% in 2025, its largest moves.
• Year by year, Restructuring Costs stood at -$1.2 million in 2022, then soared by 186.08% to $1.1 million in 2023, then soared by 1358.41% to $15.6 million in 2024, then declined by 15.0% to $13.3 million in 2025, then sank by 76.78% to $3.1 million in 2026.
• Per Business Quant data, the three most recent Restructuring Costs figures were $3.1 million in Q1 2026, $13.3 million in Q4 2025, and $9.4 million in Q3 2025.